Verrica Pharmaceuticals Stock (NASDAQ: VRCA) stock price, news, charts, stock research, profile.
You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.
Other companies in Verrica Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Marinus Pharma (NASDAQ:MRNS).
Verrica Pharmaceuticals has a consensus price target of $11.57.
The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $1.76 last updated September 24, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Verrica Pharmaceuticals.
Verrica Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Verrica Pharmaceuticals.
Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.